An optimized fermentation process for high-level production of a single-chain Fv antibody fragment in Pichia pastoris.

The expression of a humanized single-chain variable domain fragment antibody (A33scFv) was optimized for Pichia pastoris with yields exceeding 4 g L(-1). A33scFv recognizes a cell surface glycoprotein (designated A33) expressed in colon cancer that serves as a target antigen for immunotherapy of colon cancer. P. pastoris with a MutS phenotype was selected to express A33scFv, which was cloned under regulation of the methanol-inducible AOX1 promoter. We report the optimization of A33scFv production by examining methanol concentrations using fermentation technology with an on-line methanol control in fed-batch fermentation of P. pastoris. In addition, we examined the effect of pH on A33scFv production and biomass accumulation during the methanol induction phase. A33scFv production was found to increase with higher methanol concentrations, reaching 4.3 g L(-1) after 72 h induction with 0.5% (v/v) methanol. Protein production was also greatly affected by pH, resulting in higher yields (e.g., 4.88 g L(-1)) at lower pH values. Biomass accumulation did not seem to vary when cells were induced at different pH values, but was greatly affected by lower concentration of methanol. Purification of A33scFv from clarified medium was done using a two-step chromatographic procedure using anion-exchange and hydrophobic interaction chromatography, resulting in 25% recovery and >90% purity. Pure A33scFv was tested for functionality using surface plasmon resonance and showed activity against immobilized A33 antigen. Our results demonstrate that functional A33scFv can be produced in sufficient quantities using P. pastoris for use in further functionality studies and diagnostic applications.

[1]  F. Real,et al.  Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  I. J. van der Klei,et al.  Biosynthesis and assembly of alcohol oxidase, a peroxisomal matrix protein in methylotrophic yeasts: A review , 1991, Yeast.

[3]  William C. Raschke,et al.  Recent Advances in the Expression of Foreign Genes in Pichia pastoris , 1993, Bio/Technology.

[4]  J. Humm,et al.  Enhancement of radiation dose to the nucleus by vesicular internalization of iodine-125-labeled A33 monoclonal antibody. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  Wenhui Zhang,et al.  Design of Methanol Feed Control in Pichia pastoris Fermentations Based upon a Growth Model , 2002, Biotechnology progress.

[6]  A. Plückthun,et al.  High volumetric yields of functional dimeric miniantibodies in Escherichia coli, using an optimized expression vector and high-cell-density fermentation under non-limited growth conditions , 1996, Applied Microbiology and Biotechnology.

[7]  M. Alting-Mees,et al.  Optimal conditions for the expression of a single-chain antibody (scFv) gene in Pichia pastoris. , 2003, Protein expression and purification.

[8]  S. Welt,et al.  Antibodies in the therapy of colon cancer. , 1999, Seminars in oncology.

[9]  M. Romanos Advances in the use of Pichia pastoris for high-level gene expression , 1995 .

[10]  E C Nice,et al.  Kinetic analysis of the interaction between the monoclonal antibody A33 and its colonic epithelial antigen by the use of an optical biosensor. A comparison of immobilisation strategies. , 1997, Journal of chromatography. A.

[11]  J. Cregg,et al.  Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris. , 2002, Current opinion in biotechnology.

[12]  L. G. Davis,et al.  Basic methods in molecular biology , 1986 .

[13]  C. Hew,et al.  Low-temperature increases the yield of biologically active herring antifreeze protein in Pichia pastoris. , 2001, Protein expression and purification.

[14]  C. Brady,et al.  High-Level Production and Purification of P30P2MSP119, an Important Vaccine Antigen for Malaria, Expressed in the Methylotropic Yeast Pichia pastoris , 2001 .

[15]  M. Murtaugh,et al.  High-level secretion of two antibody single chain Fv fragments by Pichia pastoris. , 1997, Journal of immunological methods.

[16]  J. Bertino,et al.  A33scFv–cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy , 2003, British Journal of Cancer.

[17]  N. Kemeny,et al.  Preliminary report of a phase I study of combination chemotherapy and humanized A33 antibody immunotherapy in patients with advanced colorectal cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  N. Kemeny,et al.  Phase I study of anticolon cancer humanized antibody A33. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  E. Moreau,et al.  Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis hector. , 2001, European journal of biochemistry.

[20]  M. Gautier,et al.  High-level secretion of a wheat lipid transfer protein in Pichia pastoris. , 1998, Protein expression and purification.

[21]  A. Scott,et al.  Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  M. Ayala,et al.  Very high expression of an anti-carcinoembryonic antigen single chain Fv antibody fragment in the yeast Pichia pastoris. , 2000, Journal of biotechnology.

[23]  F. Real,et al.  Organ-specific expression of the colon cancer antigen A33, a cell surface target for antibody-based therapy. , 1996, International journal of oncology.

[24]  C. Barbas,et al.  The Rabbit Antibody Repertoire as a Novel Source for the Generation of Therapeutic Human Antibodies* , 2000, The Journal of Biological Chemistry.

[25]  K. Kairemo,et al.  Radioimmunotherapy of solid cancers: A review. , 1996, Acta oncologica.

[26]  L. Old,et al.  Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33. , 2001, Cancer research.

[27]  R. Fischer,et al.  Production of carcinoembryonic antigen (CEA) N‐A3 domain in Pichia pastoris by fermentation , 1999, Biotechnology and applied biochemistry.

[28]  K. Eskridge,et al.  Optimization of temperature–glycerol–pH conditions for a fed-batch fermentation process for recombinant hookworm ( Ancylostoma caninum) anticoagulant peptide (AcAP-5) production by Pichia pastoris 1 This paper is published as paper no. 12008 Journal Series, Nebraska Agricultral Experiment Station, L , 1999 .

[29]  U. Nielsen,et al.  Expression of single-chain Fv-Fc fusions in Pichia pastoris. , 2001, Journal of immunological methods.

[30]  D. Luo,et al.  An engineered bivalent single-chain antibody fragment that increases antigen binding activity. , 1997, Journal of biochemistry.

[31]  T. Omasa,et al.  Effect of methanol concentration on the production of human β2-glycoprotein I domain V by a recombinant Pichia pastoris: A simple system for the control of methanol concentration using a semiconductor gas sensor , 1998 .

[32]  R. Hawkins,et al.  Clinical evidence of efficient tumor targetting based on single–chain Fv antibody selected from a combinatorial library , 1996, Nature Medicine.